Answer:
Explanation:
Advantages of Anticoagulant Therapy
Anticoagulant therapy remains the mainstay of medical therapy for deep venous thrombosis (DVT) because it is non-invasive, it treats most patients (approximately 90%) with no immediate demonstrable physical sequelae of DVT, it has a low risk of complications, and its outcome data demonstrates an improvement in morbidity and mortality. Meta-analyses of randomized trials of unfractionated heparin (UFH) and low-molecular-weight heparin (LMWH) have shown that they are similar, with a 4% risk of recurrent DVT, a 2% risk of pulmonary embolism (PE), and a 3% risk of major bleeding.
It's basically a characteristic of bacteria that have a cell wall composed of a thin layer of particular substance (called peptidoglycan).
